These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 15372199

  • 1. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y.
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [Abstract] [Full Text] [Related]

  • 2. Direct current therapy with/without lidocaine iontophoresis in myofascial pain syndrome.
    Kaya A, Kamanli A, Ardicoglu O, Ozgocmen S, Ozkurt-Zengin F, Bayik Y.
    Bratisl Lek Listy; 2009 Oct; 110(3):185-91. PubMed ID: 19507642
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches.
    Venancio Rde A, Alencar FG, Zamperini C.
    Cranio; 2009 Jan; 27(1):46-53. PubMed ID: 19241799
    [Abstract] [Full Text] [Related]

  • 4. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG, Bang MS, Chung SG, Jung SH, Lee SU.
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [Abstract] [Full Text] [Related]

  • 5. Comparison of injection methods in myofascial pain syndrome: a randomized controlled trial.
    Ay S, Evcik D, Tur BS.
    Clin Rheumatol; 2010 Jan; 29(1):19-23. PubMed ID: 19838864
    [Abstract] [Full Text] [Related]

  • 6. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response.
    Hong CZ.
    Am J Phys Med Rehabil; 1994 Jan; 73(4):256-63. PubMed ID: 8043247
    [Abstract] [Full Text] [Related]

  • 7. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, Lapenna D, Giamberardino MA.
    Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
    [Abstract] [Full Text] [Related]

  • 8. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M.
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
    De Andrés J, Adsuara VM, Palmisani S, Villanueva V, López-Alarcón MD.
    Reg Anesth Pain Med; 2010 Mar; 35(3):255-60. PubMed ID: 20921836
    [Abstract] [Full Text] [Related]

  • 10. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [Abstract] [Full Text] [Related]

  • 11. Intramuscular and nerve root stimulation vs lidocaine injection to trigger points in myofascial pain syndrome.
    Ga H, Koh HJ, Choi JH, Kim CH.
    J Rehabil Med; 2007 May; 39(5):374-8. PubMed ID: 17549328
    [Abstract] [Full Text] [Related]

  • 12. Acupuncture needling versus lidocaine injection of trigger points in myofascial pain syndrome in elderly patients--a randomised trial.
    Ga H, Choi JH, Park CH, Yoon HJ.
    Acupunct Med; 2007 Dec; 25(4):130-6. PubMed ID: 18160923
    [Abstract] [Full Text] [Related]

  • 13. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T, Palmieri B, Aspiro A, Di Cerbo A.
    Drug Des Devel Ther; 2014 Dec; 8():931-5. PubMed ID: 25075176
    [Abstract] [Full Text] [Related]

  • 14. Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.
    Hong CZ, Hsueh TC.
    Arch Phys Med Rehabil; 1996 Nov; 77(11):1161-6. PubMed ID: 8931529
    [Abstract] [Full Text] [Related]

  • 15. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis.
    Ahmed S, Subramaniam S, Sidhu K, Khattab S, Singh D, Babineau J, Kumbhare DA.
    Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660
    [Abstract] [Full Text] [Related]

  • 16. Comparison of miniscalpel-needle release, acupuncture needling, and stretching exercise to trigger point in myofascial pain syndrome.
    Ma C, Wu S, Li G, Xiao X, Mai M, Yan T.
    Clin J Pain; 2010 Apr; 26(3):251-7. PubMed ID: 20173440
    [Abstract] [Full Text] [Related]

  • 17. Paraspinal stimulation combined with trigger point needling and needle rotation for the treatment of myofascial pain: a randomized sham-controlled clinical trial.
    Couto C, de Souza IC, Torres IL, Fregni F, Caumo W.
    Clin J Pain; 2014 Mar; 30(3):214-23. PubMed ID: 23629597
    [Abstract] [Full Text] [Related]

  • 18. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM.
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [Abstract] [Full Text] [Related]

  • 19. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY, Wang D.
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome].
    Gül K, Onal SA.
    Agri; 2009 Jul; 21(3):104-12. PubMed ID: 19780001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.